Topic · Case Reports on Hematomas
Most cited papers in Case Reports on Hematomas
What are the most cited papers in Case Reports on Hematomas?
The most cited paper in Case Reports on Hematomas is "Prevention of Venous Thromboembolism" (William H Geerts, Graham Frederick Pineo, John A. Heit et al., 2004), with 5,923 citations. Next come "Prevention of VTE in Orthopedic Surgery Patients" (1,939) and "Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy" (1,690).
Showing 50 of 100 papers. Every paper with more than 266 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Prevention of Venous Thromboembolism William H Geerts, Graham Frederick Pineo, John A. Heit et al. · CHEST Journal | Sep 2004 | 5,923 |
| 2 | Prevention of VTE in Orthopedic Surgery Patients Yngve T Falck-Ytter, Charles W. Francis, Norman A. Johanson et al. · CHEST Journal | Feb 2012 | 1,939 |
| 3 | Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy Alok A. Khorana, C. W. Francis, Eva Culakova et al. · Journal of Thrombosis and Haemostasis | 21 Feb 2007 | 1,690 |
| 4 | Is There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease? Richard J. Johnson, Duk‐Hee Kang, Daniel I. Feig et al. · Hypertension | 21 Apr 2003 | 1,374 |
| 5 | Gout Nicola Dalbeth, Anna L. Gosling, Angelo Gaffo et al. · The Lancet | 30 Mar 2021 | 1,346 |
| 6 | A Role for Uric Acid in the Progression of Renal Disease Duk‐Hee Kang, Takahiko Nakagawa, Lili Feng et al. · Journal of the American Society of Nephrology | Dec 2002 | 1,312 |
| 7 | Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol Pál Pacher, Alex Nivorozhkin, Csaba Szabó · Pharmacological Reviews | 28 Feb 2006 | 1,219 |
| 8 | Global epidemiology of gout: prevalence, incidence and risk factors Chang‐Fu Kuo, Matthew J. Grainge, Weiya Zhang et al. · Nature Reviews Rheumatology | 7 Jul 2015 | 1,212 |
| 9 | Hemorrhagic Complications of Anticoagulant Treatment Mark N. Levine, Gary E. Raskob, Seth Landefeld et al. · CHEST Journal | 2001 | 1,143 |
| 10 | Gout Nicola Dalbeth, Tony Raymond Merriman, Lisa K. Stamp · The Lancet | 27 Apr 2016 | 1,113 |
| 11 | Parenteral Anticoagulants David García, Trevor P Baglin, Jeffrey Ian Weitz et al. · CHEST Journal | Feb 2012 | 1,090 |
| 12 | 2020 American College of Rheumatology Guideline for the Management of Gout John D. FitzGerald et al. · Arthritis Care & Research | 11 May 2020 | 1,021 |
| 13 | Gout Pascal Richette, Thomas Bardin · The Lancet | 18 Aug 2009 | 922 |
| 14 | Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention C. Seth Landefeld, Rebecca J. Beyth · The American Journal of Medicine | Sep 1993 | 897 |
| 15 | A New Risk Scheme to Predict Warfarin-Associated Hemorrhage Margaret C. Fang, Alan S. Go, Yuchiao Chang et al. · Journal of the American College of Cardiology | Jul 2011 | 860 |
| 16 | Asymptomatic hyperuricemia. Risks and consequences in the normative aging study Edward W. Campion, Robert J. Glynn, Lorraine O. Delabry · The American Journal of Medicine | Mar 1987 | 859 |
| 17 | Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism Marilda Mazzali, John Kanellis, Lin Han et al. · American Journal of Physiology-Renal Physiology | Jun 2002 | 829 |
| 18 | Still's disease in the adult. Eric G. L. Bywaters · Annals of the Rheumatic Diseases | Mar 1971 | 770 |
| 19 | Venous thromboembolism Faizan Ahmad Khan, Tobias Tritschler, Susan R. Kahn et al. · The Lancet | 10 May 2021 | 768 |
| 20 | Parenteral Anticoagulants Jack Hirsh, Kenneth Alan Bauer, Maria Benedetta Donati et al. · CHEST Journal | Jun 2008 | 755 |
| 21 | Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment Sam Schulman, Rebecca J. Beyth, Clive Kearon et al. · CHEST Journal | Jun 2008 | 741 |
| 22 | 2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis Dinesh Khanna et al. · Arthritis Care & Research | 28 Sep 2012 | 736 |
| 23 | Decreased extra-renal urate excretion is a common cause of hyperuricemia Kimiyoshi Ichida et al. · Nature Communications | 3 Apr 2012 | 714 |
| 24 | Spinal hematoma: a literature survey with meta-analysis of 613 patients D. Kreppel, Gregor Antoniadis, Wulf Seeling · Neurosurgical Review | 2003 | 713 |
| 25 | Gout Nicola Dalbeth, Hyon K. Choi, Leo A. B. Joosten et al. · Nature Reviews Disease Primers | 26 Sep 2019 | 712 |
| 26 | Aspirin Eric H. Awtry, Joseph Loscalzo · Circulation | 14 Mar 2000 | 688 |
| 27 | Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation Richard J. Johnson, George L. Bakris, Claudio Borghi et al. · American Journal of Kidney Diseases | 27 Feb 2018 | 663 |
| 28 | Prevalence of Hyperuricemia and Gout in Mainland China from 2000 to 2014: A Systematic Review and Meta-Analysis Rui Liu, Cheng Han, Di Wu et al. · BioMed Research International | 2015 | 663 |
| 29 | Surgical management of spinal epidural hematoma: relationship between surgical timing and neurological outcome Michael T. Lawton, Randall W. Porter, Joseph E. Heiserman et al. · Journal of neurosurgery | Jul 1995 | 663 |
| 30 | Uric acid and chronic kidney disease: which is chasing which? Richard J. Johnson, Takahiko Nakagawa, Diana I. Jalal et al. · Nephrology Dialysis Transplantation | 29 Mar 2013 | 660 |
| 31 | Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: A 28‐week, phase III, randomized, double‐blind, parallel‐group trial H. Ralph Schumacher, Michael A. Becker, Robert L. Wortmann et al. · Arthritis Care & Research | 30 Oct 2008 | 637 |
| 32 | Retroperitoneal fibrosis Augusto Vaglio, Carlo Salvarani, Carlo Buzio · The Lancet | 2006 | 616 |
| 33 | Gout: An old disease in new perspective – A review Gaafar Ragab, Mohsen Hassan Elshahaly, Thomas Bardin · Journal of Advanced Research | 11 May 2017 | 615 |
| 34 | Hyperuricemia and its related diseases: mechanisms and advances in therapy Lin Du, Zong Yao, Haorui Li et al. · Signal Transduction and Targeted Therapy | 27 Aug 2024 | 613 |
| 35 | Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease Hidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima et al. · International Journal of Molecular Sciences | 26 Aug 2021 | 602 |
| 36 | Drug-Induced Acute Pancreatitis: An Evidence-Based Review Nison L. Badalov, Robin Baradarian, Kadirawel Iswara et al. · Clinical Gastroenterology and Hepatology | 29 Mar 2007 | 590 |
| 37 | EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT) Weiya Zhang, M Doherty, E Pascual et al. · Annals of the Rheumatic Diseases | 18 May 2006 | 587 |
| 38 | NEED FOR LONG-TERM ANTICOAGULANT TREATMENT IN SYMPTOMATIC CALF-VEIN THROMBOSIS Claes Lagerstedt · The Lancet | Sep 1985 | 573 |
| 39 | British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the Management of Gout Kelsey M. Jordan, J. S. Cameron, Michael L. Snaith et al. · Lara D. Veeken | 23 May 2007 | 555 |
| 40 | The Management of Gout Bryan T. Emmerson · New England Journal of Medicine | 15 Feb 1996 | 517 |
| 41 | Pelvic Fractures: Epidemiology and Predictors of Associated Abdominal Injuries and Outcomes1 Demetrios G. Demetriades, Marios Karaiskakis, Konstantinos Toutouzas et al. · Journal of the American College of Surgeons | Jul 2002 | 500 |
| 42 | Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition) Mamoru Ayusawa, Tomoyoshi Sonobe, Shigeru Uemura et al. · Pediatrics International | 16 Mar 2005 | 497 |
| 43 | Acute Eosinophilic and Neutrophilic Pneumonia following Transarterial Chemoembolization with Drug-Eluting Beads Loaded with Doxorubicin for Hepatocellular Carcinoma: A Case Report Dimitra Alifakioti, Cécile Daccord, Yann Lachenal et al. · Respiration | 2014 | 495 |
| 44 | Gout Tuhina Neogi · New England Journal of Medicine | 2 Feb 2011 | 494 |
| 45 | Epidemiology of gout and hyperuricemia Arthur P. Hall, Peter E. Barry, Thomas R. Dawber et al. · The American Journal of Medicine | 1967 | 486 |
| 46 | Gout Robert A. Terkeltaub · New England Journal of Medicine | 22 Oct 2003 | 459 |
| 47 | Acute Pulmonary Embolism Giancarlo Agnelli, Cecilia Becattini · New England Journal of Medicine | Jul 2010 | 449 |
| 48 | 2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout Pascal Richette et al. · Annals of the Rheumatic Diseases | 5 Jun 2019 | 446 |
| 49 | Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease Claudio Borghi, Enrico Agabiti‐Rosei, Richard J. Johnson et al. · European Journal of Internal Medicine | 29 Jul 2020 | 441 |
| 50 | Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures Eugenia Nikolsky, Roxana Mehran, Amir Halkin et al. · Journal of the American College of Cardiology | Sep 2004 | 440 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.